United Therapeutics Corporation
UTHR
$483.08
$3.130.65%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
5/2/2025
-
MarketBeat
12/2/2025
-
Benzinga
12/2/2025
-
MarketBeat
12/1/2025
-
MarketBeat
11/30/2025
-
MarketBeat
11/30/2025
-
MarketBeat
11/29/2025
-
Simply Wall St
11/28/2025
-
MarketBeat
11/27/2025
-
MarketBeat
11/27/2025
-
MarketBeat
11/27/2025
-
MarketBeat
11/27/2025
-
Ticker Report
11/27/2025
-
MarketBeat
11/26/2025
-
MarketBeat
11/26/2025
-
MarketBeat
11/26/2025
-
Ticker Report
11/26/2025
-
Ticker Report
11/26/2025
-
MarketBeat
11/26/2025
-
Ticker Report
11/26/2025
-
MarketBeat
11/26/2025
-
MarketBeat
11/26/2025
-
MarketBeat
11/26/2025
-
MarketBeat
11/25/2025
-
Zolmax
11/25/2025
-
Ticker Report
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Wednesday, October 29, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Feb 23 and 27 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
301 608 9292
Address
1000 Spring Street
Silver Spring, MD 20910
Silver Spring, MD 20910
Country
Year Founded
Business Description
Sector
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and...
more